Centre extends deadline for ₹5,000 crore pharma R&D scheme. Here’s why?

₹5,000 crore government initiative is aimed at positioning India as the “laboratory of the world”.”/>
₹5000 crore scheme,pharma r&d funding,centre deadline extended,generics to innovation,india pharma hub,research and innovation,NCE development,make in india pharma,healthcare R&D,pharma startups,MSME pharma grants,NIPER research,priority pathogens,orphan drugs”/>
₹5000 crore scheme,pharma r&d funding,centre deadline extended,generics to innovation,india pharma hub,research and innovation,NCE development,make in india pharma,healthcare R&D,pharma startups,MSME pharma grants,NIPER research,priority pathogens,orphan drugs”/>